Abstract
Genetic instability was one of the first characteristics to be postulated to underlie neoplasia1,2,3. Such genetic instability occurs in two different forms. In a small fraction of colorectal and some other cancers, defective repair of mismatched bases results in an increased mutation rate at the nucleotide level and consequent widespread microsatellite instability4,5,6,7. In most colorectal cancers, and probably in many other cancer types, a chromosomal instability (CIN) leading to an abnormal chromosome number (aneuploidy) is observed8. The physiological and molecular bases of this pervasive abnormality are unknown. Here we show that CIN is consistently associated with the loss of function of a mitotic checkpoint. Moreover, in some cancers displaying CIN the loss of this checkpoint was associated with the mutational inactivation of a human homologue of the yeast BUB1 gene; BUB1 controls mitotic checkpoints and chromosome segregation in yeast. The normal mitotic checkpoints of cells displaying microsatellite instability become defective upon transfer of mutant hBUB1 alleles from either of two CIN cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boveri, T. Zur Frage der Entstehung maligner Tumoren vol. 1 (Gustav Fischer, Jena, 1914).
Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991).
Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71, 543–546 (1992).
Perucho, M. Cancer of the microsatellite mutator phenotype. Biol. Chem. 377, 675–684 (1996).
Modrich, P. Strand-specific mismatch repair in mammalian cells. J. Biol. Chem. 272, 24727–24730 (1997).
Kolodner, R. D. Mismatch repair — mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 20, 397–401 (1995).
Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colon cancer. Cell 87, 159–170 (1996).
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623–627 (1997).
Strand, M., Prolla, T. A., Liskay, R. M. & Petes, T. D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365, 274–276 (1993).
Murray, A. W. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev. 5, 5–11 (1995).
Nasmyth, K. At the heart of the budding yeast cell cycle. Trends Genet. 12, 405–412 (1996).
Paulovich, A. G., Toczyski, D. P. & Hartwell, L. H. When checkpoints fail. Cell 88, 315–321 (1997).
Nicklas, R. B. How cells get the right chromosomes. Science 275, 632–637 (1997).
Li, R. & Murray, A. W. Feedback control of mitosis in budding yeast. Cell 66, 519–531 (1991).
Roberts, B. T., Farr, K. A. & Hoyt, M. A. The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol. Cell Biol. 14, 8282–8291 (1994).
Hardwick, K. G., Weiss, E., Luca, F. C., Winey, M. & Murray, A. W. Activation of the budding yeast spindle assembly checkpoint without mitotic spindle disruption. Science 273, 953–956 (1996).
Pangilinan, F. & Spencer, F. Abnormal kinetochore structure activates the spindle assembly checkpoint in budding yeast. Mol. Biol. Cell 7, 1195–1208 (1996).
Taylor, S. S. & McKeon, F. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89, 727–735 (1997).
Hanks, S. K. & Quinn, A. M. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200, 38–62 (1991).
Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246–248 (1996).
Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches into the discovery of anticancer drugs. Science 278, 1064–1068 (1997).
Waldman, T., Lengauer, C., Kinzler, K. W. & Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713–716 (1996).
Polyak, K., Waldman, T., He, T.-C., Kinzler, K. W. & Vogelstein, B. Genetic determinants of p53 induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1996).
Liu, B.et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet. 9, 48–55 (1995).
Lengauer, C.et al. Large-scale isolation of human 1p36-specific P1 clones and their use for fluorescence in situ hybridization. Genet. Anal. Tech. Appl. 11, 140–147 (1994).
Parsons, R.et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55, 5548–5550 (1995).
Riggins, G. J., Kinzler, K. W., Vogelstein, B. & Thiagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res. 57, 2578–2580 (1997).
Jen, J.et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 331, 213–221 (1994).
Pangilinan, F.et al. Mammalian BUB1 protein kinases: map positions and in vivo expression. Genomics 46, 379–388 (1997).
Acknowledgements
We thank S. Laken for assistance with the microdissection of tumours, J. Flook for assistance with flow cytometry, and T. Henn for assistance with FISH. This work was supported by the Clayton Fund and grants from the NIH. B.V. and S.D.M. are Investigators of the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cahill, D., Lengauer, C., Yu, J. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998). https://doi.org/10.1038/32688
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/32688
This article is cited by
-
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies
Scientific Reports (2024)
-
Can precancerous stem cells be risk markers for malignant transformation in the oral mucosa?
Cellular & Molecular Biology Letters (2023)
-
E3-ubiquitin ligase, FBXW7 regulates mitotic progression by targeting BubR1 for ubiquitin-mediated degradation
Cellular and Molecular Life Sciences (2023)
-
Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation
Oncogene (2022)
-
Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1
Cell & Bioscience (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.